Loading... Please wait... Loading... Please wait...
(AS OF MARCH 31)
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue | 05/23/2024 | Q1 2024 | -$0.36 | $89.58 M | 03/21/2024 | Q4 2023 | -$0.08 | $93.01 M | 09/29/2023 | Q3 2023 | $0.03 | $84.18 M | 09/01/2023 | Q2 2023 | -$0.17 | $76.68 M | 05/10/2023 | Q1 2023 | -$0.22 | $71.23 M | 04/27/2023 | Q4 2022 | $0.04 | $74.02 M | 11/17/2022 | Q3 2022 | $0.13 | $71.68 M | 09/13/2022 | Q2 2022 | $0.17 | $62.57 M | 05/12/2022 | Q1 2022 | $0.28 | $62.39 M | 03/29/2022 | Q4 2021 | $0.28 | $67.91 M | 09/29/2021 | Q3 2021 | $0.06 | $65.89 M | 06/29/2021 | Q2 2021 | $0.04 | $59.17 M | 03/30/2021 | Q1 2021 | $0.02 | $53.28 M | 12/30/2020 | Q4 2020 | $0.02 | $57.17 M | 09/29/2020 | Q3 2020 | $0.04 | $53.24 M | 06/29/2020 | Q2 2020 | -$0.01 | $45.77 M |
|---|
A. The conference call for Cellebrite DI Ltd.'s latest earnings report can be listened to online.
A. The conference call transcript for Cellebrite DI Ltd.'s latest earnings report can be read online.
A. Cellebrite DI Ltd. (NASDAQ:CLBTW) has a recorded annual revenue of $325.11 M.
A. Cellebrite DI Ltd. (NASDAQ:CLBTW) has a recorded net income of $325.11 M. Cellebrite DI Ltd. has generated $-0.43 earnings per share over the last four quarters.
A. Cellebrite DI Ltd. (NASDAQ:CLBTW) has a price-to-earnings ratio of -21.47 and price/earnings-to-growth ratio is -1.23.
